Orthofix International N.V. (NASDAQ:OFIX) – Equities researchers at Gabelli boosted their FY2020 earnings per share estimates for Orthofix International N.V. in a research note issued on Wednesday. Gabelli analyst J. Tsai now forecasts that the medical device company will post earnings of $2.20 per share for the year, up from their prior forecast of $2.05.

OFIX has been the subject of a number of other reports. Zacks Investment Research upgraded Orthofix International N.V. from a “hold” rating to a “buy” rating and set a $60.00 price objective for the company in a research note on Thursday, November 2nd. TheStreet downgraded Orthofix International N.V. from a “b” rating to a “c+” rating in a research note on Tuesday, October 31st. BTIG Research set a $56.00 price objective on Orthofix International N.V. and gave the stock a “buy” rating in a research note on Monday, October 30th. BidaskClub upgraded Orthofix International N.V. from a “hold” rating to a “buy” rating in a research note on Thursday, August 17th. Finally, Jefferies Group LLC restated a “buy” rating and set a $55.00 price objective (up from $50.00) on shares of Orthofix International N.V. in a research note on Thursday, August 10th. Seven investment analysts have rated the stock with a buy rating, The company currently has an average rating of “Buy” and a consensus price target of $54.42.

COPYRIGHT VIOLATION WARNING: “FY2020 EPS Estimates for Orthofix International N.V. (OFIX) Increased by Analyst” was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another website, it was stolen and reposted in violation of U.S. and international copyright and trademark legislation. The original version of this piece can be viewed at https://www.watchlistnews.com/fy2020-eps-estimates-for-orthofix-international-n-v-ofix-increased-by-analyst/1686115.html.

Shares of Orthofix International N.V. (NASDAQ:OFIX) traded down $0.39 during midday trading on Monday, hitting $51.23. The stock had a trading volume of 121,310 shares, compared to its average volume of 160,616. Orthofix International N.V. has a 1-year low of $32.51 and a 1-year high of $54.33. The company has a market cap of $946.01, a P/E ratio of 33.92, a price-to-earnings-growth ratio of 2.57 and a beta of 0.15.

Orthofix International N.V. (NASDAQ:OFIX) last issued its quarterly earnings results on Monday, October 30th. The medical device company reported $0.42 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.41 by $0.01. Orthofix International N.V. had a return on equity of 10.26% and a net margin of 0.33%. The business had revenue of $105.30 million during the quarter, compared to the consensus estimate of $100.67 million. During the same period in the previous year, the business earned $0.36 EPS. The business’s quarterly revenue was up 6.9% on a year-over-year basis.

In related news, CEO Brad Mason sold 2,733 shares of the company’s stock in a transaction on Monday, August 21st. The stock was sold at an average price of $48.10, for a total transaction of $131,457.30. Following the completion of the transaction, the chief executive officer now directly owns 188,053 shares in the company, valued at approximately $9,045,349.30. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Rice Doug sold 7,353 shares of the company’s stock in a transaction on Monday, September 11th. The stock was sold at an average price of $49.46, for a total value of $363,679.38. Following the transaction, the chief financial officer now owns 44,743 shares of the company’s stock, valued at $2,212,988.78. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 23,406 shares of company stock valued at $1,138,531. 5.60% of the stock is owned by company insiders.

A number of hedge funds have recently made changes to their positions in OFIX. Pinebridge Investments L.P. boosted its position in Orthofix International N.V. by 2.3% during the 2nd quarter. Pinebridge Investments L.P. now owns 2,378 shares of the medical device company’s stock worth $111,000 after acquiring an additional 53 shares during the period. State of Alaska Department of Revenue boosted its position in Orthofix International N.V. by 79.3% during the 2nd quarter. State of Alaska Department of Revenue now owns 3,551 shares of the medical device company’s stock worth $165,000 after acquiring an additional 1,571 shares during the period. Municipal Employees Retirement System of Michigan acquired a new position in Orthofix International N.V. during the 2nd quarter worth $196,000. UBS Asset Management Americas Inc. acquired a new position in Orthofix International N.V. during the 1st quarter worth $229,000. Finally, New York State Teachers Retirement System acquired a new position in Orthofix International N.V. during the 1st quarter worth $262,000. Institutional investors own 93.81% of the company’s stock.

About Orthofix International N.V.

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Earnings History and Estimates for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.